Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 17, 2025, titled "AstraZeneca Pharma India Limited and Sun Pharma partner to help patients living with Hyperkalaemia in India".
Press Release Nov 17 2025
Filed with NSE · · 4 pages · English
Release
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Nov 12 2025
- Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
- Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
- Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
- Press Release Jul 21 2025
Later from Sun Pharmaceutical Industries
- FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
- Press Release Nov 26 2025
- Sun Pharmaceutical Industries Limited Press Release Dec 01 2025
- Sun Pharma Launches ILUMYA® In India
- ILUMYA® (tildrakizumab) Pen (Auto-Injector) Now Available for Canadians Living with Moderate-to-Severe Plaque Psoriasis
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries